Series A - AmacaThera

Series A - AmacaThera

Investment Firm

Overview

AmacaThera's injectable hydrogel platform provides localized, sustained drug delivery to improve patient outcomes.

Announced Date

Nov 28, 2023

Funding Type

Series A

Highlights

Location

North America

Social

Investor Lead

N/A

Participant Investors

4

Investor Name
Participant InvestorBDC Capital’s Women in Technology Venture Fund
Participant InvestorStandUp Ventures
Participant InvestorInveready
Participant InvestorMaRS Investment Accelerator Fund

Round Details and Background

AmacaThera raised $2948465 on 2023-11-28 in Series A

AmacaThera's injectable hydrogel platform provides localized, sustained drug delivery to improve patient outcomes.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 22, 2021
Series A - AmacaThera
9-10.3M
Jan 04, 2023
Grant - AmacaThera
1-undefined
Nov 28, 2023
Series A - AmacaThera
6-2.9M
Dec 01, 2023
Grant - AmacaThera
1-50.0K

Recent Activity

There is no recent news or activity for this profile.